BA three-lens brief

Evidence-based stock research on BA. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of Jul 10
$176.77$221.55$254.35

Performance

1W
-2.2%
1M
+4.3%
3M
+1.8%
6M
-5.5%
YTD
+2.0%
1Y
-2.0%
3Y
5Y
BA · Nightly brief
Inspect

Analyst mean target $270.44 — 22% above current (25 analysts). · P/E of 88 — priced for high growth; little margin of safety.

  • P/E of 88 — priced for high growth; little margin of safety.
  • Analyst mean target $270.44 — 22% above current (25 analysts).
  • Debt-to-equity of 829% — balance-sheet-heavy.
  • Earnings scheduled 2026-07-28.

BA closed at $221.55 (-0.70%) as of 2026-07-10. Market cap: $174.65B. P/E (trailing) 87.9. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $270.44 — 22% above current (25 analysts).. Concerns: p/E of 88 — priced for high growth; little margin of safety.; debt-to-equity of 829% — balance-sheet-heavy.. Last quarter: Revenue $22.22B, net income -$90.00M, free cash flow $2.55B. Watching for: 2026-07-28 earnings release (17 days out).

Market ✓· Fundamentals ✓· 1 events· Sentiment ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on BA, not one.

A single reasoning model has blind spots it doesn’t know about. We examine BAacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/BA"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath BA brief"></iframe>